🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
This is a single-arm, open-label, phase 1b study evaluating the safety and ...
Status
Recruiting
Location
Froedtert & the Medical College of Wisconsin
Start Date
2025-12-02
Trial ID
NCT07093554
Treatments Being Tested
The purpose of this study is to evaluate how well (efficacy) cilta-cel work...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-10-03
Trial ID
NCT07149857
Treatments Being Tested
The purpose of the study is to characterize safety of JNJ-68284528 and esta...
Status
Completed
Location
Mayo Clinic Cancer Center-Scottsdale
Start Date
2018-06-29
Trial ID
NCT03548207
Treatments Being Tested
This is an open-label, single arm, multicenter, interventional study with D...
Status
Recruiting
Location
Hospital Clinico Universitario Salamanca
Start Date
2024-09-30
Trial ID
NCT06574126
The purpose of this individual-patient investigational new drug (IND) singl...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04452994
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of LCAR-B3...
Status
Terminated
Location
Peking University Third Hospital
Start Date
2019-01-23
Trial ID
NCT03758417
Treatments Being Tested
The outcomes in patients with relapsed multiple myeloma refractory to tripl...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-03-17
Trial ID
NCT07200102
Treatments Being Tested
The purpose of this study is to compare the efficacy of Bortezomib, Lenalid...
Status
Active Not Recruiting
Location
UCSF
Start Date
2021-08-19
Trial ID
NCT04923893
Treatments Being Tested